The Israeli company recalled some vials of the drug in July 2009, and the FDA recently sent the company a warning letter about violations found at its Irvine, Calif., plant, according to the report.
APP Pharmaceuticals and Hospira are both manufacturing and distributing propofol. The FDA allowed APP to import a similar European product earlier this year after the American Society of Anesthesiologists raised concerns over the shortage.
Read the Wall Street Journal’s report on the propofol shortage.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.